Join
Live feed
·
NEWSReleasevia Quantisnow
Brickell Biotech Inc. logo

Brickell Biotech Has Received A Notice Of Allowance For Its Us Patent Application 17/105,376 Titled "Crystalline Form Of Sofpironium Bromide And Preparation Method Thereof (For The Treatment Of Hyperhidrosis)".

ByQuantisnow·Wall Street's wire, on your screen.
BBI· Brickell Biotech Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBI (Brickell Biotech Inc.) and more on Quantisnow.

Brickell Biotech Has Received A Notice Of Allowance For Its Us Patent Application 17/105,376 Titled "Crystalline Form Of Sofpironium Bromide And Preparation Method Thereof (For The Treatment Of Hyperhidrosis)". | Quantisnow